Aptamer Group (LSE:APTA) Gross-Profit-to-Asset % : -1.55% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Aptamer Group's annualized Gross Profit for the quarter that ended in Dec. 2023 was £-0.05 Mil. Aptamer Group's average Total Assets over the quarter that ended in Dec. 2023 was £3.36 Mil. Therefore, Aptamer Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was -1.55%.

Aptamer Group Gross-Profit-to-Asset % Historical Data

The historical data trend for Aptamer Group's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Gross-Profit-to-Asset % Chart

Aptamer Group Annual Data

Trend

Mar19

Mar20

Jun22

Jun23

Gross-Profit-to-Asset %

43.88

32.72

41.60

5.03

Aptamer Group Semi-Annual Data
	Mar19	Mar20	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			15.34	35.65	9.07	-3.42	-1.55

Competitive Comparison of Aptamer Group's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Aptamer Group's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptamer Group's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Aptamer Group's Gross-Profit-to-Asset % falls into.

Aptamer Group Gross-Profit-to-Asset % Calculation

Aptamer Group's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Jun. 2023 )	/	( (Total Assets (A: Jun. 2022 )	+	Total Assets (A: Jun. 2023 ))	/ count )
	=	0.359	/	( (11.52	+	2.753)	/ 2 )
	=	0.359	/	7.1365
	=	5.03 %

Aptamer Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-0.052	/	( (2.753	+	3.968)	/ 2 )
	=	-0.052	/	3.3605
	=	-1.55 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Aptamer Group Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptamer Group (LSE:APTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Innovation Way, Windmill House, York, GBR, YO10 5BR

Website

https://www.aptamergroup.com

Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines